# IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE

> **NCT02023671** · — · UNKNOWN · sponsor: **Azienda Ospedaliera San Giovanni Battista** · enrollment: 70 (actual)

## Conditions studied

- Multiple Myeloma
- Post Allografting

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02023671
- **Lead sponsor:** Azienda Ospedaliera San Giovanni Battista
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2014-12
- **Final completion:** —
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2013-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02023671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02023671, "IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02023671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*